PreciseDx
About PreciseDx
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series B T: - FT: Series B |
A: 20700000 MR: - FA: 20.7 million FAN: 20700000 |
D: 2024-08-21 FD: 2024-08-21 |
4 investors |
Growth Metrics
Team & Leadership
Carlos Cordon-Cardo
Professor and Chair of Pathology, Molecular and Cell-Based Medicine
Eric Converse
Chief Executive Officer
Ed Sitar
Chief financial officer
Gerardo Fernandez
Chief scientific officer, Co-Founder
Michael Donovan
Chief Medical Officer, Co-Founder
Ted M. Diehl
VP, Commercial
Recent News
PreciseDx Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- precisedx.ai
- Industries
- Healthcare
- Company Size
- ~360 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro